Back
Autodesk, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
58
ADSK
Autodesk, Inc.
Last Price:
$297.70
Seasonality Move:
2.72%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.65
Seasonality Move:
9.28%
Buy
58
Autodesk, Inc. (ADSK)
is a Buy
Is Autodesk, Inc. a Buy, Sell or Hold?
-
The current Autodesk, Inc. [ADSK] share price is $297.64. The Score for ADSK is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
ADSK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADSK Stock Price Chart
What is Autodesk, Inc.'s stock price today?
-
The Autodesk, Inc. share price today is $297.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADSK is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.12 | Sell |
| Relative Strength Index (14 RSI): | 44.96 | Sell |
| Chaikin Money Flow: | -818041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (293.05 - 304.89) | Sell |
| Bollinger Bands (100): | (292.65 - 317.19) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.57 | Buy |
| Relative Strength Index (14 RSI): | 86.06 | Buy |
| Chaikin Money Flow: | 367727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151.4 - 242.46) | Buy |
| Bollinger Bands (100): | (51.44 - 167.06) | Buy |
ADSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 302.58 | Sell |
| 20-day SMA: | 298.88 | Sell |
| 50-day SMA: | 303.05 | Sell |
| 200-day SMA: | 293.33 | Buy |
| 8-day EMA: | 300.98 | Sell |
| 20-day EMA: | 300.89 | Sell |
| 50-day EMA: | 302.55 | Sell |
| 200-day EMA: | 296.57 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.33 | Buy |
| 20-day SMA: | 219.69 | Buy |
| 50-day SMA: | 150.04 | Buy |
| 200-day SMA: | 68.84 | Buy |
| 8-day EMA: | 219.45 | Buy |
| 20-day EMA: | 204.15 | Buy |
| 50-day EMA: | 162.92 | Buy |
| 200-day EMA: | 88.08 | Buy |
Autodesk, Inc. Earnings Growth & ADSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.07 per share, an increase this year of $0.84 per share, and an increase next year of $1.91 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Autodesk, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||